These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8328041)

  • 21. [Price differences between generic and innovator medicines in Brazil].
    Vieira FS; Zucchi P
    Rev Saude Publica; 2006 Jun; 40(3):444-9. PubMed ID: 16810368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huge price variations in generic drugs.
    James JS
    AIDS Treat News; 2003 May; (391):7-8. PubMed ID: 12866499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 24. Is medicines parallel trade 'regulatory arbitrage'?
    Costa-Font J
    Int J Health Econ Manag; 2016 Dec; 16(4):321-336. PubMed ID: 27878693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors].
    Mahlich JC; Stadler I
    Gesundheitswesen; 2012 Jan; 74(1):23-8. PubMed ID: 21154203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Who's really raising drug prices?
    Zagorin A
    Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of being first: evidence from Canadian generic pharmaceuticals.
    Hollis A
    Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Price survey. Generic drug market heats up.
    Hosp Mater Manage; 2001 Mar; 26(3):1, 12-3. PubMed ID: 11975141
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of privatization of the drug distribution system on drug prices in Malaysia.
    Babar ZD; Izham MI
    Public Health; 2009 Aug; 123(8):523-33. PubMed ID: 19665741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
    Gross DJ; Schondelmeyer SW; Raetzman SO
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy on 180-day marketing exclusivity for drugs marketed under abbreviated new drug applications; clarification--FDA. Clarification.
    Fed Regist; 1997 Nov; 62(229):63268-9. PubMed ID: 10177950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Generic substitution, replacement and substitution of drugs: contemporary extent].
    Macesková B; Blechová R; Blahozová E; Hadámková K
    Ceska Slov Farm; 2011 Apr; 60(2):73-8. PubMed ID: 21650009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring the price of new drugs.
    Silversides A
    CMAJ; 2006 May; 174(11):1548-9. PubMed ID: 16717260
    [No Abstract]   [Full Text] [Related]  

  • 35. Parallel trade of pharmaceuticals: The Danish market for statins.
    Méndez SJ
    Health Econ; 2018 Feb; 27(2):333-356. PubMed ID: 28868645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RX for nosebleed prices.
    Greenwald J
    Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
    [No Abstract]   [Full Text] [Related]  

  • 37. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of price-cap regulations on market entry by generic pharmaceutical firms.
    Zhang W; Sun H; Guh D; Anis AH
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):231-238. PubMed ID: 27936981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generic medicine pricing in Europe: current issues and future perspective.
    Simoens S
    J Med Econ; 2008; 11(1):171-5. PubMed ID: 19450118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.